Grifols, S. A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions.
Grifols Sa stock last closed at $9.88, down 1.59% from the previous day, and has increased 8.45% in one year. It has overperformed other stocks in the Drug Manufacturers - General industry by 0.2 percentage points. Grifols Sa stock is currently +59.61% from its 52-week low of $6.19, and -11.31% from its 52-week high of $11.14.
There are currently 687.55M GRFS shares outstanding. The market capitalization of GRFS is $6.79B. In the past 24 hours, 360,000 GRFS shares were traded.
How to Buy Grifols Sa Stock
Not sure how to invest in Grifols Sa stock? Here's how.
Figure out where to buy Grifols Sa stock: You need to choose an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you decide where to buy Grifols Sa stock.
Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
Fund your investment account: Select your payment method and add your information.
Research Grifols Sa stock: The Grifols Sa ticker symbol is GRFS. Is Grifols Sa stock a good investment? Should you buy shares of GRFS? How do GRFS's underlying business fundamentals look? Do top analysts think Grifols Sa is a good buy? Why has GRFS's stock price moved recently? (Hint: Our stock research tools can help you figure out if GRFS is a good stock to buy).
Execute your GRFS trade: Decide if you will purchase GRFS shares at the current market price or use a limit order to purchase GRFS shares at a specific price.
Get the latest scoop on your investment in GRFS: Create a watchlist to watch your new investment in Grifols Sa shares.
Step 1: Figure out where to buy Grifols Sa stock
You will need an online brokerage account to access the NASDAQ market and buy GRFS stock.
A brokerage account allows you to buy and sell a number of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
In our opinion, eToro is the best stock brokerage. Here's why:
Invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
Access to world markets: From Technology to Financial Services, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by opening an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've selected the right brokerage, the next step is to fill out some personal details so you can buy GRFS stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Grifols Sa stock
Once you have chosen the best place to buy Grifols Sa stock, it's very important to analyze their stock before you buy, so you actually wrap your head around the risk and opportunity.
Grifols Sa Numbers
GRFS Price
$9.88
1w %
-2.47%
1y %
8.45%
5y %
-40.3%
P/E
38.59x
P/B
1.04x
P/S
0.85x
PEG
0.33x
Revenue
$8.01B
Earnings
$174.36M
Fore. Rev. Growth
8.76%
Fore. Earn. Growth
128.42%
Market Cap
$6.79B
Next Earnings
Nov 6, 2025
Next Dividend
N/A
Grifols Sa Due Diligence Score
WallStreetZen was created to help everyday investors do better fundamental analysis in minutes instead of hours.
Last year, GRFS earnings were $174.36M. In the last 5 year, GRFS's earnings have increased by -25.16% per year. This was slower than the Drug Manufacturers - General industry average of 6.11%.
Last year, GRFS revenue was $8.01B. Over the past 5 year, GRFS's revenue has gone up by 5.57% per year. This was slower than the Drug Manufacturers - General industry average of 9.92%.
Grifols Sa pays a dividend of 1.75%, compared to the Drug Manufacturers - General industry's average dividend yield of 3.03%. If you owned $1,000 worth of GRFS stock, you would have been paid $17.55 in the past 12 months.
Grifols Sa dividend payments have not consistently grown over the past decade and have not remained stable.
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Execute your GRFS trade
There are two main order types:
Market order: A market order is an order to buy or sell a stock at the best possible price. Market orders are usually the best for newer investors.
Limit order: A limit order is an order to buy or sell a security at a specific price (or better). If you want to make sure you're buying or selling at a given dollar amount limit, place a limit order.
Click the Open button and eToro will place your order.
If you require additional assistance investing in stocks on eToro, click the how to video below:
How much does it cost to buy one Grifols Sa share?
As of Sep 12, 2025, it costs $9.88 to buy one share of Grifols Sa stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $4, you can buy 0.405 shares of GRFS.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.